A citation-based method for searching scientific literature

Linda E Kelemen, Kate Lawrenson, Jonathan Tyrer, Qiyuan Li, Janet M Lee, Ji-Heui Seo, Catherine M Phelan, Jonathan Beesley, Xiaoqing Chen, Tassja J Spindler, Katja K H Aben, Hoda Anton-Culver, Natalia Antonenkova. Nat Genet 2015
Times Cited: 60







List of co-cited articles
473 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Paul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, Catherine M Phelan, Ellen L Goode, Kate Lawrenson, Melissa Buckley, Brooke L Fridley, Jonathan P Tyrer, Howard Shen,[...]. Nat Genet 2013
245
46

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, Susan J Ramus, Maria Notaridou, Kate Lawrenson, Martin Widschwendter, Robert A Vierkant, Melissa C Larson, Susanne K Kjaer,[...]. Nat Genet 2010
257
40

Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Kelly L Bolton, Jonathan Tyrer, Honglin Song, Susan J Ramus, Maria Notaridou, Chris Jones, Tanya Sher, Aleksandra Gentry-Maharaj, Eva Wozniak, Ya-Yu Tsai,[...]. Nat Genet 2010
190
38


A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Honglin Song, Susan J Ramus, Jonathan Tyrer, Kelly L Bolton, Aleksandra Gentry-Maharaj, Eva Wozniak, Hoda Anton-Culver, Jenny Chang-Claude, Daniel W Cramer, Richard DiCioccio,[...]. Nat Genet 2009
222
36

Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Karoline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, Andrew Lee, Howard C Shen, Jonathan Beesley, Kate Lawrenson, Lesley McGuffog, Sue Healey, Janet M Lee,[...]. Nat Genet 2015
145
35

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Catherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, Siddhartha P Kar, Kate Lawrenson, Stacey J Winham, Joe Dennis, Ailith Pirie, Marjorie J Riggan, Ganna Chornokur,[...]. Nat Genet 2017
130
30

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, Aneliya Velkova, Jonathan P Tyrer, Zhihua Chen, Hui-Yi Lin, Y Ann Chen, Ya-Yu Tsai, Xiaotao Qu,[...]. Nat Commun 2013
77
28

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, Hilda A Pickett, Howard C Shen, Chanel E Smart,[...]. Nat Genet 2013
383
28

Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.
Kexin Chen, Hongxia Ma, Lian Li, Rongyu Zang, Cheng Wang, Fengju Song, Tingyan Shi, Dianke Yu, Ming Yang, Wenqiong Xue,[...]. Nat Commun 2014
42
35

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Hui Shen, Brooke L Fridley, Honglin Song, Kate Lawrenson, Julie M Cunningham, Susan J Ramus, Mine S Cicek, Jonathan Tyrer, Douglas Stram, Melissa C Larson,[...]. Nat Commun 2013
117
25

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Siddhartha P Kar, Jonathan Beesley, Ali Amin Al Olama, Kyriaki Michailidou, Jonathan Tyrer, ZSofia Kote-Jarai, Kate Lawrenson, Sara Lindstrom, Susan J Ramus, Deborah J Thompson,[...]. Cancer Discov 2016
82
20

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
Ludmila Prokunina-Olsson, Brian Muchmore, Wei Tang, Ruth M Pfeiffer, Heiyoung Park, Harold Dickensheets, Dianna Hergott, Patricia Porter-Gill, Adam Mumy, Indu Kohaar,[...]. Nat Genet 2013
627
18

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.
Georgina L Ryland, Sally M Hunter, Maria A Doyle, Franco Caramia, Jason Li, Simone M Rowley, Michael Christie, Prue E Allan, Andrew N Stephens, David D L Bowtell,[...]. Genome Med 2015
81
16

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Fergus J Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Karoline B Kuchenbaecker, Penny Soucy, Zachary Fredericksen, Daniel Barrowdale, Joe Dennis,[...]. PLoS Genet 2013
183
16

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
Kate Lawrenson, Qiyuan Li, Siddhartha Kar, Ji-Heui Seo, Jonathan Tyrer, Tassja J Spindler, Janet Lee, Yibu Chen, Alison Karst, Ronny Drapkin,[...]. Nat Commun 2015
30
30

Integrative eQTL-based analyses reveal the biology of breast cancer risk loci.
Qiyuan Li, Ji-Heui Seo, Barbara Stranger, Aaron McKenna, Itsik Pe'er, Thomas Laframboise, Myles Brown, Svitlana Tyekucheva, Matthew L Freedman. Cell 2013
223
13

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
Michael S Anglesio, Stefan Kommoss, Mary C Tolcher, Blaise Clarke, Laura Galletta, Henry Porter, Sambasivarao Damaraju, Sian Fereday, Boris J Winterhoff, Steve E Kalloger,[...]. J Pathol 2013
116
13

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Dongliang Ge, Jacques Fellay, Alexander J Thompson, Jason S Simon, Kevin V Shianna, Thomas J Urban, Erin L Heinzen, Ping Qiu, Arthur H Bertelsen, Andrew J Muir,[...]. Nature 2009
13

IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections.
Tsion Zewdu Minas, Wei Tang, Cheryl J Smith, Olusegun O Onabajo, Adeola Obajemu, Tiffany H Dorsey, Symone V Jordan, Obadi M Obadi, Bríd M Ryan, Ludmila Prokunina-Olsson,[...]. Commun Biol 2018
16
50

Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Simon G Coetzee, Howard C Shen, Dennis J Hazelett, Kate Lawrenson, Karoline Kuchenbaecker, Jonathan Tyrer, Suhn K Rhie, Keren Levanon, Alison Karst, Ronny Drapkin,[...]. Hum Mol Genet 2015
26
26


Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Jonathan Tyrer, Jonathan Beesley, Susan J Ramus, Qiyuan Li, Melissa K Delgado,[...]. Nat Commun 2016
43
16

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.
Mohammed Eslam, Ahmed M Hashem, Reynold Leung, Manuel Romero-Gomez, Thomas Berg, Gregory J Dore, Henry L K Chan, William L Irving, David Sheridan, Maria L Abate,[...]. Nat Commun 2015
118
11

IL-28, IL-29 and their class II cytokine receptor IL-28R.
Paul Sheppard, Wayne Kindsvogel, Wenfeng Xu, Katherine Henderson, Stacy Schlutsmeyer, Theodore E Whitmore, Rolf Kuestner, Ursula Garrigues, Carl Birks, Jenny Roraback,[...]. Nat Immunol 2003
11

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Mohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, Alessandra Mangia, Thomas Berg, Khaled Thabet, William L Irving, Gregory J Dore, David Sheridan, Henning Grønbæk,[...]. Nat Genet 2017
58
12

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
Sergei V Kotenko, Grant Gallagher, Vitaliy V Baurin, Anita Lewis-Antes, Meiling Shen, Nital K Shah, Jerome A Langer, Faruk Sheikh, Harold Dickensheets, Raymond P Donnelly. Nat Immunol 2003
11

Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4).
Felix M Key, Benjamin Peter, Megan Y Dennis, Emilia Huerta-Sánchez, Wei Tang, Ludmila Prokunina-Olsson, Rasmus Nielsen, Aida M Andrés. PLoS Genet 2014
58
12

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M Near, Penelope M Webb, Christina M Nagle, Jennifer A Doherty, Kara L Cushing-Haugen, Kristine G Wicklund,[...]. Lancet Oncol 2012
520
10

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.
Viviane Hess, Roger A'Hern, Nazar Nasiri, D Michael King, Peter R Blake, Desmond P J Barton, John H Shepherd, T Ind, J Bridges, K Harrington,[...]. J Clin Oncol 2004
215
10

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
201
10

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
Honglin Song, Ed Dicks, Susan J Ramus, Jonathan P Tyrer, Maria P Intermaggio, Jane Hayward, Christopher K Edlund, David Conti, Patricia Harrington, Lindsay Fraser,[...]. J Clin Oncol 2015
162
10

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
10


Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
10

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.
Ewa Terczyńska-Dyla, Stephanie Bibert, Francois H T Duong, Ilona Krol, Sanne Jørgensen, Emilie Collinet, Zoltán Kutalik, Vincent Aubert, Andreas Cerny, Laurent Kaiser,[...]. Nat Commun 2014
88
10

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama, Masayuki Kurosaki, Kentaro Matsuura, Naoya Sakamoto, Mina Nakagawa, Masaaki Korenaga, Keisuke Hino, Shuhei Hige,[...]. Nat Genet 2009
10

Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
Peter V Aka, Mark H Kuniholm, Ruth M Pfeiffer, Alan S Wang, Wei Tang, Sabrina Chen, Jacquie Astemborski, Michael Plankey, Maria C Villacres, Marion G Peters,[...]. J Infect Dis 2014
69
10

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Vijayaprakash Suppiah, Max Moldovan, Golo Ahlenstiel, Thomas Berg, Martin Weltman, Maria Lorena Abate, Margaret Bassendine, Ulrich Spengler, Gregory J Dore, Elizabeth Powell,[...]. Nat Genet 2009
10

IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
Adeola A Obajemu, Nina Rao, Kari A Dilley, Joselin M Vargas, Faruk Sheikh, Raymond P Donnelly, Reed S Shabman, Eric G Meissner, Ludmila Prokunina-Olsson, Olusegun O Onabajo. J Immunol 2017
39
15

Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
Thomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, Krystle A Lang Kuhs, Sabrina Chen, Herbert L Bonkovsky, Brian R Edlin, Charles D Howell, Gregory D Kirk, Mark H Kuniholm,[...]. J Hepatol 2015
49
12

Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Salvatore Petta, Luca Valenti, Antonino Tuttolomondo, Paola Dongiovanni, Rosaria Maria Pipitone, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Anna Ludovica Fracanzani, Sara Badiali,[...]. Hepatology 2017
49
12

IFNL4-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.
Wei Tang, Tiffany A Wallace, Ming Yi, Cristina Magi-Galluzzi, Tiffany H Dorsey, Olusegun O Onabajo, Adeola Obajemu, Symone V Jordan, Christopher A Loffredo, Robert M Stephens,[...]. Clin Cancer Res 2018
19
31


Rethinking ovarian cancer: recommendations for improving outcomes.
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, Andy Berchuck, Jonathan S Berek, James D Brenton, George Coukos, Christopher C Crum, Ronny Drapkin, Dariush Etemadmoghadam,[...]. Nat Rev Cancer 2011
792
8

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
J Alexandre, I Ray-Coquard, F Selle, A Floquet, P Cottu, B Weber, C Falandry, D Lebrun, E Pujade-Lauraine. Ann Oncol 2010
58
8


Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
Mary L Gemignani, Alan C Schlaerth, Faina Bogomolniy, Richard R Barakat, Oscar Lin, Robert Soslow, Ennapandam Venkatraman, Jeff Boyd. Gynecol Oncol 2003
150
8


Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
Muneaki Shimada, Junzo Kigawa, Yoshihiro Ohishi, Makoto Yasuda, Mitsuaki Suzuki, Masamichi Hiura, Ryuichiro Nishimura, Tsutomu Tabata, Toru Sugiyama, Tsunehisa Kaku. Gynecol Oncol 2009
93
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.